Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Endo to Buy Auxilium in Deal Worth $2.6B

By Pharmaceutical Processing | October 9, 2014

Ireland’s Endo International is planning to buy Auxilium Pharmaceuticals in a sweetened cash-and-stock deal valued at $2.6 billion a few weeks after Auxilium rejected a lower bid. The Auxilium board embraced the latest offer but its shareholders get to vote on it.

Endo said Thursday that it will pay $33.25 in cash and stock for each Auxilium share. That represents a 55 percent premium to Auxilium’s closing price on Sept. 16, the day Endo went public with its acquisition attempt.

Endo International PLC initially offered $28.10 per share in a bid valued at $2.2 billion, which like the revised offer includes the assumption of debt. But Auxilium Pharmaceuticals Inc. said on Sept. 22 that the bid undervalued its business, and it recommended that shareholders vote for a separate, all-stock combination with Canadian eye drugmaker QLT Inc.

Auxilium, which is based in Chesterbrook, Pennsylvania, also said a day after Endo announced its initial bid that its board had adopted a “poison pill” shareholder rights plan to discourage unsolicited takeovers.

Last Friday, Auxilium said that it ended its proposed deal with QLT. The boards of both Endo and Auxilium have unanimously approved the higher bid. If Auxilium shareholders approve the deal, the companies expect the deal to close in the first half of next year.

Auxilium shareholders will be able to choose an all-cash, all-stock or cash-and-stock payment in the revised bid.

Auxilium is struggling with reduced sales of its testosterone gel Testim and said last month that it would cut about 190 jobs, or 30 percent of its workforce, as part of a plan to save $75 million per year.

The company also makes Xiaflex, a drug approved to treat two rare conditions: Dupuytren’s contracture, which makes the tendons of the hand thicken and shorten, and Peyronie’s disease, which causes abnormal curvature of the penis.

Endo has transformed itself from a drug company to a larger drug and medical device maker over the course of several years and a spate of acquisitions. It moved its headquarters to Dublin, Ireland, from the United States as part of a $1.5 billion purchase of Paladin Labs the company announced last year. It also changed its name to Endo International PLC from Endo Health Solutions.

Shares of Auxilium jumped nearly 11 percent, or $3.18, to $32.94 in premarket trading Thursday about an hour before markets opened. That put the stock up 59 percent so far this year. Meanwhile, U.S.-traded shares of Endo fell $1.34, or 1.9 percent, to $69.66 in premarket trading.

Related Articles Read More >

Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE